Inactive Instrument

Analyst Reco. Compugen Ltd. TEL AVIV STOCK EXCHANGE

Equities

Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating	Mar. 08	MT
Exchange-Traded Funds, US Equities Rise Pre-Bell Tuesday as Investors Continue to Hope for Federal Reserve Rate Cuts Soon	Dec. 19	MT
Oppenheimer Adjusts Compugen's Price Target to $7 From $8, Maintains Outperform Rating	23-05-16	MT
Jefferies Downgrades Compugen to Underperform From Hold, Lowers Price Target to $0.50 from $2	23-02-08	MT
EF Hutton Initiates Compugen at Buy With $13 Price Target	23-01-05	MT
Oppenheimer Adjusts Compugen PT to $8 From $12, Updates Model to Reflect Evolving Development Strategy; Maintains Outperform Rating	22-11-15	MT
Truist Securities Adjusts Compugen's Price Target to $4 From $14, Reiterates Buy Rating	22-08-23	MT
JMP Securities Adjusts Price Target on Compugen to $4 From $8, Maintains Market Outperform Rating	22-08-08	MT
Oppenheimer Adjusts Compugen Price Target to $12 From $14, Maintains Outperform Rating	22-08-05	MT
Stifel Adjusts Compugen's Price Target to $5 From $12, Reiterates Buy Rating	22-08-05	MT
Jefferies Downgrades Compugen to Hold From Buy; Price Target is $2	22-08-05	MT
SVB Leerink Adjusts Compugen's Price Target to $9 from $16, Maintains Outperform Rating	22-02-25	MT
Oppenheimer Adjusts Compugen's Price Target to $14 From $17, Maintains Outperform Rating	22-02-25	MT
Oppenheimer Adjusts Compugen PT to $17 From $19, Maintains Outperform Rating	21-11-15	MT
COMPUGEN : SVB Leerink Adjusts Price Target on Compugen to $16 From $19, Maintains Outperform Rating	21-04-06	MT

No results for this search